Tag Archive | "Actavis"

Actavis and Grunenthal terminate Cebranopadol pact

Tags: , , ,


Grunenthal announced the termination of the license agreement with Actavis for the development and commercialization of Cebranopadol Read the full story

Actavis agrees to acquire Allergan in $66 billion deal

Tags: , , , ,


Actavis and Allergan have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock Read the full story

Both, Actavis and Sanofi competing for Omega Pharma

Tags: ,


Several companies are rumored to be competing to acquire Omega Pharma, the fastest growing consumer healthcare company in the U.K. and Ireland. Read the full story

Actavis acquires Durata Therapeutics for $675 million

Tags: , ,


Actavis and Durata Therapeutics have inked a definitive  agreement to acquire Durata Therapeutics for $675 million. Read the full story

Is Pfizer’s next acquisition target, Actavis?

Tags: , ,


Bloomberg reports, Pfizer is looking at Actavis, the generics maker with a new home address in Ireland, among other targets. Read the full story

Impax buys two generic drugs from Actavis

Tags: , , ,


Impax Laboratories has acquired from Actavis two generic products for cash consideration pursuant to a Purchase Agreement and a Supply Agreement. Read the full story

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


The term ‘top pharma’ can relate to the top pharmaceutical companies or the top 10 or 50… Read the full story

Actavis

Tags: , ,


Actavis is a top pharmaceutical company based in New Jersey, USA Read the full story

Actavis enters into a settlement agreement with Valeant

Tags: , ,


Actavis has entered into an agreement with Valeant Pharmaceuticals to settle all outstanding patent litigation related to Actavis’ generic version of Acanya (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/2.5%. Read the full story

Actavis signs a pharma deal to acquire topical products from Akorn

Tags: , , ,


Actavis has entered into pharma deal agreements with Akorn and Hi-Tech Pharmacal to purchase four currently marketed products and one product under development for cash consideration. Read the full story

cabannerad300x150new4gif
biovariabanner300x150gif
biowales-300x150-enjpg
RSS Feed Linked In Twitter

Latest Tweets

cabannerad300x150new4gif
lesi-web-bannerjpg
p2078300x150bannercpjpg